Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations (original) (raw)

Abstract

The major risk factors for hepatocellular carcinomas (HCC) in high incidence areas include infection with hepatitis B and C viruses (HBV, HCV) and exposure to aflatoxin. Genetic alterations in 24 liver resection specimens from Shanghai and Qidong were studied. Hepatitis B virus was integrated in all patient samples, and a null phenotype for the GSTM1 enzyme was present in 63% of patients. Alteration of p53 was present in 95% (23/24) of cases: mutations of the p53 gene in 12 HCC, p53 overexpression in 13 and loss of heterozygosity (LOH) of chromosome 17p in 17. All seven HCCs with a p53 mutation from Qidong and three of five from Shanghai had the aflatoxin-associated point mutation with a G to T transversion at codon 249, position 3. No HCC had microsatellite instability. LOH of chromosome 4q, 1p, 16q and 13q was present in 50%, 46%, 42% and 38%, respectively, and 4q was preferentially lost in HCCs containing a p53 mutation: LOH of 4q was present in 75% (9/12) of HCC with, but only 25% (3/12) of HCC without, a p53 gene mutation (P = 0.01). These data indicate a possible interaction between p53 gene mutation and 4q loss in the pathogenesis of HCC. © 1999 Cancer Research Campaign

Keywords: p53 gene, loss of heterozygosity, hepatitis B virus, aflatoxin, hepatocellular carcinomas

Full Text

The Full Text of this article is available as a PDF (204.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aguilar F., Hussain S. P., Cerutti P. Aflatoxin B1 induces the transversion of G-->T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8586–8590. doi: 10.1073/pnas.90.18.8586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bankfalvi A., Navabi H., Bier B., Böcker W., Jasani B., Schmid K. W. Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry. J Pathol. 1994 Nov;174(3):223–228. doi: 10.1002/path.1711740312. [DOI] [PubMed] [Google Scholar]
  3. Becker S. A., Zhou Y. Z., Slagle B. L. Frequent loss of chromosome 8p in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res. 1996 Nov 1;56(21):5092–5097. [PubMed] [Google Scholar]
  4. Boige V., Laurent-Puig P., Fouchet P., Fléjou J. F., Monges G., Bedossa P., Bioulac-Sage P., Capron F., Schmitz A., Olschwang S. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res. 1997 May 15;57(10):1986–1990. [PubMed] [Google Scholar]
  5. Bourdon J. C., D'Errico A., Paterlini P., Grigioni W., May E., Debuire B. p53 protein accumulation in European hepatocellular carcinoma is not always dependent on p53 gene mutation. Gastroenterology. 1995 Apr;108(4):1176–1182. doi: 10.1016/0016-5085(95)90217-1. [DOI] [PubMed] [Google Scholar]
  6. Bressac B., Kew M., Wands J., Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 1991 Apr 4;350(6317):429–431. doi: 10.1038/350429a0. [DOI] [PubMed] [Google Scholar]
  7. Brockmöller J., Kerb R., Drakoulis N., Nitz M., Roots I. Genotype and phenotype of glutathione S-transferase class mu isoenzymes mu and psi in lung cancer patients and controls. Cancer Res. 1993 Mar 1;53(5):1004–1011. [PubMed] [Google Scholar]
  8. Buetow K. H., Murray J. C., Israel J. L., London W. T., Smith M., Kew M., Blanquet V., Brechot C., Redeker A., Govindarajah S. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8852–8856. doi: 10.1073/pnas.86.22.8852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chen H. L., Chen Y. C., Chen D. S. Chromosome 1p aberrations are frequent in human primary hepatocellular carcinoma. Cancer Genet Cytogenet. 1996 Feb;86(2):102–106. doi: 10.1016/0165-4608(95)00186-7. [DOI] [PubMed] [Google Scholar]
  10. Comstock K. E., Sanderson B. J., Claflin G., Henner W. D. GST1 gene deletion determined by polymerase chain reaction. Nucleic Acids Res. 1990 Jun 25;18(12):3670–3670. doi: 10.1093/nar/18.12.3670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Coursaget P., Depril N., Chabaud M., Nandi R., Mayelo V., LeCann P., Yvonnet B. High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal. Br J Cancer. 1993 Jun;67(6):1395–1397. doi: 10.1038/bjc.1993.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. De Souza A. T., Hankins G. R., Washington M. K., Orton T. C., Jirtle R. L. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet. 1995 Dec;11(4):447–449. doi: 10.1038/ng1295-447. [DOI] [PubMed] [Google Scholar]
  13. Devilee P., van Vliet M., Bardoel A., Kievits T., Kuipers-Dijkshoorn N., Pearson P. L., Cornelisse C. J. Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma. Cancer Res. 1991 Feb 1;51(3):1020–1025. [PubMed] [Google Scholar]
  14. Dracopoli N. C., Harnett P., Bale S. J., Stanger B. Z., Tucker M. A., Housman D. E., Kefford R. F. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci U S A. 1989 Jun;86(12):4614–4618. doi: 10.1073/pnas.86.12.4614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dumenco L., Oguey D., Wu J., Messier N., Fausto N. Introduction of a murine p53 mutation corresponding to human codon 249 into a murine hepatocyte cell line results in growth advantage, but not in transformation. Hepatology. 1995 Oct;22(4 Pt 1):1279–1288. doi: 10.1016/0270-9139(95)90640-1. [DOI] [PubMed] [Google Scholar]
  16. Döhner H., Bloomfield C. D., Frizzera G., Frestedt J., Arthur D. C. Recurring chromosome abnormalities in Hodgkin's disease. Genes Chromosomes Cancer. 1992 Nov;5(4):392–398. doi: 10.1002/gcc.2870050415. [DOI] [PubMed] [Google Scholar]
  17. Emi M., Fujiwara Y., Nakajima T., Tsuchiya E., Tsuda H., Hirohashi S., Maeda Y., Tsuruta K., Miyaki M., Nakamura Y. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res. 1992 Oct 1;52(19):5368–5372. [PubMed] [Google Scholar]
  18. Fujimori M., Tokino T., Hino O., Kitagawa T., Imamura T., Okamoto E., Mitsunobu M., Ishikawa T., Nakagama H., Harada H. Allelotype study of primary hepatocellular carcinoma. Cancer Res. 1991 Jan 1;51(1):89–93. [PubMed] [Google Scholar]
  19. Gleeson C. M., Sloan J. M., McGuigan J. A., Ritchie A. J., Weber J. L., Russell S. E. Allelotype analysis of adenocarcinoma of the gastric cardia. Br J Cancer. 1997;76(11):1455–1465. doi: 10.1038/bjc.1997.578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Greenblatt M. S., Feitelson M. A., Zhu M., Bennett W. P., Welsh J. A., Jones R., Borkowski A., Harris C. C. Integrity of p53 in hepatitis B x antigen-positive and -negative hepatocellular carcinomas. Cancer Res. 1997 Feb 1;57(3):426–432. [PubMed] [Google Scholar]
  21. Groopman J. D., Wang J. S., Scholl P. Molecular biomarkers for aflatoxins: from adducts to gene mutations to human liver cancer. Can J Physiol Pharmacol. 1996 Feb;74(2):203–209. [PubMed] [Google Scholar]
  22. Hammoud Z. T., Kaleem Z., Cooper J. D., Sundaresan R. S., Patterson G. A., Goodfellow P. J. Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res. 1996 Oct 1;56(19):4499–4502. [PubMed] [Google Scholar]
  23. Hampton G. M., Larson A. A., Baergen R. N., Sommers R. L., Kern S., Cavenee W. K. Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma. Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6704–6709. doi: 10.1073/pnas.93.13.6704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hayashi H., Sugio K., Matsumata T., Adachi E., Takenaka K., Sugimachi K. The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan. Hepatology. 1995 Dec;22(6):1702–1707. [PubMed] [Google Scholar]
  25. Henkler F., Waseem N., Golding M. H., Alison M. R., Koshy R. Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma. Cancer Res. 1995 Dec 15;55(24):6084–6091. [PubMed] [Google Scholar]
  26. Hsu H. C., Peng S. Y., Lai P. L., Sheu J. C., Chen D. S., Lin L. I., Slagle B. L., Butel J. S. Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients. Cancer. 1994 Jan 1;73(1):42–47. doi: 10.1002/1097-0142(19940101)73:1<42::aid-cncr2820730109>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  27. Hsu I. C., Metcalf R. A., Sun T., Welsh J. A., Wang N. J., Harris C. C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 1991 Apr 4;350(6317):427–428. doi: 10.1038/350427a0. [DOI] [PubMed] [Google Scholar]
  28. Hsu I. C., Tokiwa T., Bennett W., Metcalf R. A., Welsh J. A., Sun T., Harris C. C. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis. 1993 May;14(5):987–992. doi: 10.1093/carcin/14.5.987. [DOI] [PubMed] [Google Scholar]
  29. Inazawa J., Ariyama T., Abe T., Druck T., Ohta M., Huebner K., Yanagisawa J., Reed J. C., Sato T. PTPN13, a fas-associated protein tyrosine phosphatase, is located on the long arm of chromosome 4 at band q21.3. Genomics. 1996 Jan 15;31(2):240–242. doi: 10.1006/geno.1996.0039. [DOI] [PubMed] [Google Scholar]
  30. Katagiri T., Nakamura Y., Miki Y. Mutations in the BRCA2 gene in hepatocellular carcinomas. Cancer Res. 1996 Oct 15;56(20):4575–4577. [PubMed] [Google Scholar]
  31. Kubicka S., Trautwein C., Schrem H., Tillmann H., Manns M. Low incidence of p53 mutations in European hepatocellular carcinomas with heterogeneous mutation as a rare event. J Hepatol. 1995 Oct;23(4):412–419. doi: 10.1016/0168-8278(95)80199-5. [DOI] [PubMed] [Google Scholar]
  32. Kuroki T., Fujiwara Y., Nakamori S., Imaoka S., Kanematsu T., Nakamura Y. Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q. Br J Cancer. 1995 Aug;72(2):383–385. doi: 10.1038/bjc.1995.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kuroki T., Fujiwara Y., Tsuchiya E., Nakamori S., Imaoka S., Kanematsu T., Nakamura Y. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity of chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Genes Chromosomes Cancer. 1995 Jul;13(3):163–167. doi: 10.1002/gcc.2870130305. [DOI] [PubMed] [Google Scholar]
  34. Leister I., Weith A., Brüderlein S., Cziepluch C., Kangwanpong D., Schlag P., Schwab M. Human colorectal cancer: high frequency of deletions at chromosome 1p35. Cancer Res. 1990 Nov 15;50(22):7232–7235. [PubMed] [Google Scholar]
  35. Leon M., Kew M. C. Loss of heterozygosity in chromosome 4q12-q13 in hepatocellular carcinoma in southern African blacks. Anticancer Res. 1996 Jan-Feb;16(1):349–351. [PubMed] [Google Scholar]
  36. Marchio A., Meddeb M., Pineau P., Danglot G., Tiollais P., Bernheim A., Dejean A. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer. 1997 Jan;18(1):59–65. [PubMed] [Google Scholar]
  37. McGlynn K. A., Rosvold E. A., Lustbader E. D., Hu Y., Clapper M. L., Zhou T., Wild C. P., Xia X. L., Baffoe-Bonnie A., Ofori-Adjei D. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2384–2387. doi: 10.1073/pnas.92.6.2384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Mitra A. B., Murty V. V., Li R. G., Pratap M., Luthra U. K., Chaganti R. S. Allelotype analysis of cervical carcinoma. Cancer Res. 1994 Aug 15;54(16):4481–4487. [PubMed] [Google Scholar]
  39. Nagai H., Pineau P., Tiollais P., Buendia M. A., Dejean A. Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene. 1997 Jun 19;14(24):2927–2933. doi: 10.1038/sj.onc.1201136. [DOI] [PubMed] [Google Scholar]
  40. Nasarek A., Werner M., Nolte M., Klempnauer J., Georgii A. Trisomy 1 and 8 occur frequently in hepatocellular carcinoma but not in liver cell adenoma and focal nodular hyperplasia. A fluorescence in situ hybridization study. Virchows Arch. 1995;427(4):373–378. doi: 10.1007/BF00199385. [DOI] [PubMed] [Google Scholar]
  41. Nasir J., Theilmann J. L., Chopra V., Jones A. M., Walker D., Rasper D. M., Vaillancourt J. P., Hewitt J. E., Nicholson D. W., Hayden M. R. Localization of the cell death genes CPP32 and Mch-2 to human chromosome 4q. Mamm Genome. 1997 Jan;8(1):56–59. doi: 10.1007/s003359900349. [DOI] [PubMed] [Google Scholar]
  42. Ning Y., Weber J. L., Killary A. M., Ledbetter D. H., Smith J. R., Pereira-Smith O. M. Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4. Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5635–5639. doi: 10.1073/pnas.88.13.5635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Nose H., Imazeki F., Ohto M., Omata M. p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan. Cancer. 1993 Jul 15;72(2):355–360. doi: 10.1002/1097-0142(19930715)72:2<355::aid-cncr2820720208>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  44. Pershouse M. A., El-Naggar A. K., Hurr K., Lin H., Yung W. K., Steck P. A. Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma. Oncogene. 1997 Jan 23;14(3):369–373. doi: 10.1038/sj.onc.1200836. [DOI] [PubMed] [Google Scholar]
  45. Polascik T. J., Cairns P., Chang W. Y., Schoenberg M. P., Sidransky D. Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma. Cancer Res. 1995 Nov 15;55(22):5396–5399. [PubMed] [Google Scholar]
  46. Ponchel F., Puisieux A., Tabone E., Michot J. P., Fröschl G., Morel A. P., Frébourg T., Fontanière B., Oberhammer F., Ozturk M. Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor beta 1-mediated apoptosis. Cancer Res. 1994 Apr 15;54(8):2064–2068. [PubMed] [Google Scholar]
  47. Qian G. S., Ross R. K., Yu M. C., Yuan J. M., Gao Y. T., Henderson B. E., Wogan G. N., Groopman J. D. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):3–10. [PubMed] [Google Scholar]
  48. Rashid A., Hamilton S. R. Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. Gastroenterology. 1997 Jul;113(1):127–135. doi: 10.1016/s0016-5085(97)70087-8. [DOI] [PubMed] [Google Scholar]
  49. Redston M. S., Caldas C., Seymour A. B., Hruban R. H., da Costa L., Yeo C. J., Kern S. E. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res. 1994 Jun 1;54(11):3025–3033. [PubMed] [Google Scholar]
  50. Shi C. Y., Phang T. W., Lin Y., Wee A., Li B., Lee H. P., Ong C. N. Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore. Br J Cancer. 1995 Jul;72(1):146–149. doi: 10.1038/bjc.1995.291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Simon D., Knowles B. B., Weith A. Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene. 1991 May;6(5):765–770. [PubMed] [Google Scholar]
  52. Slagle B. L., Zhou Y. Z., Birchmeier W., Scorsone K. A. Deletion of the E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinomas. Hepatology. 1993 Oct;18(4):757–762. doi: 10.1002/hep.1840180402. [DOI] [PubMed] [Google Scholar]
  53. Takahashi K., Kudo J., Ishibashi H., Hirata Y., Niho Y. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology. 1993 May;17(5):794–799. [PubMed] [Google Scholar]
  54. Tsuda H., Zhang W. D., Shimosato Y., Yokota J., Terada M., Sugimura T., Miyamura T., Hirohashi S. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6791–6794. doi: 10.1073/pnas.87.17.6791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Ueda H., Ullrich S. J., Gangemi J. D., Kappel C. A., Ngo L., Feitelson M. A., Jay G. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet. 1995 Jan;9(1):41–47. doi: 10.1038/ng0195-41. [DOI] [PubMed] [Google Scholar]
  56. Urano Y., Watanabe K., Lin C. C., Hino O., Tamaoki T. Interstitial chromosomal deletion within 4q11-q13 in a human hepatoma cell line. Cancer Res. 1991 Mar 1;51(5):1460–1464. [PubMed] [Google Scholar]
  57. Verhaegh G. W., Jongmans W., Jaspers N. G., Natarajan A. T., Oshimura M., Lohman P. H., Zdzienicka M. Z. A gene that regulates DNA replication in response to DNA damage is located on human chromosome 4q. Am J Hum Genet. 1995 Nov;57(5):1095–1103. [PMC free article] [PubMed] [Google Scholar]
  58. Walker G. J., Hayward N. K., Falvey S., Cooksley W. G. Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res. 1991 Aug 15;51(16):4367–4370. [PubMed] [Google Scholar]
  59. Wang H. P., Rogler C. E. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet Cell Genet. 1988;48(2):72–78. doi: 10.1159/000132593. [DOI] [PubMed] [Google Scholar]
  60. Weith A., Martinsson T., Cziepluch C., Brüderlein S., Amler L. C., Berthold F., Schwab M. Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chromosomes Cancer. 1989 Nov;1(2):159–166. doi: 10.1002/gcc.2870010209. [DOI] [PubMed] [Google Scholar]
  61. Yeh S. H., Chen P. J., Chen H. L., Lai M. Y., Wang C. C., Chen D. S. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res. 1994 Aug 1;54(15):4188–4192. [PubMed] [Google Scholar]
  62. Yeh S. H., Chen P. J., Lai M. Y., Chen D. S. Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: association with elevated alpha-fetoprotein production. Gastroenterology. 1996 Jan;110(1):184–192. doi: 10.1053/gast.1996.v110.pm8536855. [DOI] [PubMed] [Google Scholar]
  63. Yu M. W., Chen C. J. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol. 1994 Oct;17(2):71–91. doi: 10.1016/1040-8428(94)90020-5. [DOI] [PubMed] [Google Scholar]
  64. Yumoto Y., Hanafusa T., Hada H., Morita T., Ooguchi S., Shinji N., Mitani T., Hamaya K., Koide N., Tsuji T. Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma. J Gastroenterol Hepatol. 1995 Mar-Apr;10(2):179–185. doi: 10.1111/j.1440-1746.1995.tb01075.x. [DOI] [PubMed] [Google Scholar]
  65. Zhang W. D., Hirohashi S., Tsuda H., Shimosato Y., Yokota J., Terada M., Sugimura T. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res. 1990 Feb;81(2):108–111. doi: 10.1111/j.1349-7006.1990.tb02534.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Zhang X., Xu H. J., Murakami Y., Sachse R., Yashima K., Hirohashi S., Hu S. X., Benedict W. F., Sekiya T. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res. 1994 Aug 1;54(15):4177–4182. [PubMed] [Google Scholar]